-
公开(公告)号:DE3225879A1
公开(公告)日:1984-01-12
申请号:DE3225879
申请日:1982-07-10
Applicant: BASF AG
Inventor: HIMMELE WALTER DR , HEBERLE WOLFGANG DR , KOHLMANN FRIEDRICH-WILHELM DR , WESENBERG WALTER
IPC: A61K31/13 , A61K20060101 , A61P31/04 , A61P31/10 , C07C67/00 , C07C209/00 , C07C209/72 , C07C211/17 , C07D20060101 , C07C85/24 , C07C87/34 , C07C87/40
-
122.
公开(公告)号:DE3323330A1
公开(公告)日:1984-01-05
申请号:DE3323330
申请日:1983-06-29
Applicant: BASF AG
Inventor: HIMMELE WALTER DR , FRITZ GERHARD DR , JANSEN KLAAS
IPC: C07C41/06 , C07C43/162 , C07C43/166 , C07C45/49 , C07C47/198 , C07C47/277 , C11B9/00 , C07C45/50 , A61K7/46 , C11D3/50
Abstract: O-Substituted 2-hydroxypropanals of the general formula I in which R represents a phenyl radical or a cyclohexyl radical which can be substituted by an alkyl group having 1 to 4 C atoms or an alkoxy group having 1 to 4 C atoms and R and R can be identical or different and in each case represent H or an aliphatic radical having 1 to 4 C atoms, as well as odoriferous compositions containing these compounds. To prepare the novel compounds, alcohols of the formula II are reacted with acetylene in a manner known per se at increased temperature in the presence of alkali metal catalysts, and the resulting vinyl ethers of the general formula (III) are hydroformylated in a manner known per se in the presence of rhodium compounds. The compounds according to the invention are very good odoriferous substances which have interesting notes and a comparatively exceedingly good retention.
-
公开(公告)号:DE3060419D1
公开(公告)日:1982-07-01
申请号:DE3060419
申请日:1980-09-10
Applicant: BASF AG
Inventor: GOETZ NORBERT DR , HIMMELE WALTER DR , HUPFER LEOPOLD DR
IPC: C07D265/30 , B01J23/60 , B01J23/656 , C07B61/00 , C07D295/023
-
公开(公告)号:DE3060408D1
公开(公告)日:1982-07-01
申请号:DE3060408
申请日:1980-05-08
Applicant: BASF AG
Inventor: HIMMELE WALTER DR , POMMER ERNST-HEINRICH DR
IPC: A01N27/00 , A01N33/02 , A01N43/36 , A01N43/40 , A01N43/46 , A01N43/84 , A01P3/00 , C07C13/18 , C07D211/06 , C07D295/02 , C07D295/03
-
公开(公告)号:DE2720612A1
公开(公告)日:1978-11-16
申请号:DE2720612
申请日:1977-05-07
Applicant: BASF AG
IPC: A01N43/40 , A01N45/00 , A01N49/00 , C07D211/74
Abstract: Valuable novel 3,5-dimethyl-piperidin-4-one compounds, substituted at the nitrogen by a long-chain radical, which have a good fungicidal action, and a process for combating fungi by means of these compounds.
-
公开(公告)号:CH599084A5
公开(公告)日:1978-05-12
申请号:CH727676
申请日:1976-06-09
Applicant: BASF AG
Inventor: HIMMELE WALTER DR , HUPFER LEOPOLD DR , TOUSSAINT HERBERT DR , PAUL GERHARD DR
IPC: C07C49/175 , C07C41/42 , C07C45/00 , C07C67/00 , C07C45/24
-
127.
公开(公告)号:DE2252945A1
公开(公告)日:1974-05-09
申请号:DE2252945
申请日:1972-10-28
Applicant: BASF AG
Inventor: HIMMELE WALTER DR , SIEGEL HARDO DR , AMANN AUGUST DR , GIERTZ HUBERT PROF DR
Abstract: 1-Aminomethyl-acenaphthenes of formula (I):- (where R5 is a heterocyclic residue, alkyl or alkenyl substd. by heterocyclic, alkoxy and/or carboxy gps. or alkenylcarbonyl or alkylcarbonyl substd. by heterocyclic, alkoxy, aroxy and/or carboxy gps.; and R6 is H, an araliphatic, (cyclo)aliphatic or aromatic residue, NH2, OH, alkylamino, -SO2-R3 (R3 = aliphatic or aromatic residue), -CON(R4)2 (each R4 = H or an aliphatic or aromatic residue), or alkenyl, alkyl, alkenylcarbonyl or alkylcarbonyl substd. by heterocyclic, alkoxy, aroxy and/or carboxy gps.), are prepd. by reacting 1-formyl-acenaphthene with HNR5R6 and with a reducing agent. (I) are CNS active and have hypotensive and antiinflammatory props.
-
公开(公告)号:CH541986A
公开(公告)日:1973-09-30
申请号:CH1441470
申请日:1970-09-29
Applicant: BASF AG
Inventor: KNIESE WILHELM DR , HANS JUERGEN DR NIENBURG , HIMMELE WALTER DR , AQUILA WERNER DR
-
公开(公告)号:CH532000A
公开(公告)日:1972-12-31
申请号:CH1321270
申请日:1970-09-04
Applicant: BASF AG
Inventor: HIMMELE WALTER DR , AQUILA WERNER DR
IPC: C07C69/003 , B01J31/00 , C07B61/00 , C07C20060101 , C07C47/00 , C07C69/00 , C07C69/16 , C07C69/28 , C07C69/66 , C07C69/78
-
公开(公告)号:DE1941632B1
公开(公告)日:1971-05-19
申请号:DE1941632
申请日:1969-08-16
Applicant: BASF AG
Inventor: HIMMELE WALTER DR , AQUILA WERNER DR
-
-
-
-
-
-
-
-
-